Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Managing comorbidities in patients at the end of life.

Literature DB >> 15485977

Managing comorbidities in patients at the end of life.

James Stevenson¹, Amy P Abernethy, Cathy Miller, David C Currow.

Abstract

Entities: Species

Mesh：

Year: 2004 PMID： 15485977 PMCID： PMC523125 DOI： 10.1136/bmj.329.7471.909

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

20 in total

1. Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway.

Authors: H Olsen; T Klemetsrud; H P Stokke; S Tretli; A Westheim
Journal: Blood Press Date: 1999 Impact factor: 2.835

Review 2. Clinical preventive medicine in primary care: background and practice: 1. Rationale and current preventive practices.

Authors: D D Hensrud
Journal: Mayo Clin Proc Date: 2000-02 Impact factor: 7.616

3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

4. The cessation of cancer treatment as a crisis.

Authors: E M Arnold
Journal: Soc Work Health Care Date: 1999

5. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996.

Authors: J W Coebergh; M L Janssen-Heijnen; P N Post; P P Razenberg
Journal: J Clin Epidemiol Date: 1999-12 Impact factor: 6.437

6. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors: B Neal; S MacMahon; N Chapman
Journal: Lancet Date: 2000-12-09 Impact factor: 79.321

7. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection.

Authors: R Colven; R D Harrington; D H Spach; C J Cohen; T M Hooton
Journal: Ann Intern Med Date: 2000-09-19 Impact factor: 25.391

8. Contribution of adverse drug reactions to hospital admission of older patients.

Authors: C K Mannesse; F H Derkx; M A de Ridder; A J Man in 't Veld; T J van der Cammen
Journal: Age Ageing Date: 2000-01 Impact factor: 10.668

9. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors:
Journal: Lancet Date: 2001-09-29 Impact factor: 79.321

Review 10. Cachexia.

Authors: D P Kotler
Journal: Ann Intern Med Date: 2000-10-17 Impact factor: 25.391

40 in total

1. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group.

Authors: Amy P Abernethy; Noreen M Aziz; Ethan Basch; Janet Bull; Charles S Cleeland; David C Currow; Diane Fairclough; Laura Hanson; Joshua Hauser; Danielle Ko; Linda Lloyd; R Sean Morrison; Shirley Otis-Green; Steve Pantilat; Russell K Portenoy; Christine Ritchie; Graeme Rocker; Jane L Wheeler; S Yousuf Zafar; Jean S Kutner
Journal: J Palliat Med Date: 2010-11-24 Impact factor: 2.947

Review 2. [Multimorbidity of neurological patients in palliative care units].

Authors: S Lorenzl
Journal: Nervenarzt Date: 2014-04 Impact factor: 1.214

3. Developing the evidence base for palliative care: formation of the Palliative Care Research Cooperative and its first trial.

Authors: Thomas W LeBlanc; Jean S Kutner; Danielle Ko; Jane L Wheeler; Janet Bull; Amy P Abernethy
Journal: Hosp Pract (1995) Date: 2010

Managing comorbidities in patients at the end of life.

1. Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway.

Review 2. Clinical preventive medicine in primary care: background and practice: 1. Rationale and current preventive practices.

3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

4. The cessation of cancer treatment as a crisis.

5. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996.

6. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

7. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection.

8. Contribution of adverse drug reactions to hospital admission of older patients.

9. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Review 10. Cachexia.

1. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group.

Review 2. [Multimorbidity of neurological patients in palliative care units].

3. Developing the evidence base for palliative care: formation of the Palliative Care Research Cooperative and its first trial.

4. Side effects deserve greater emphasis at end of life.

Review 5. Comorbid disease and cancer: the need for more relevant conceptual models in health services research.

6. Withdrawing medication: managing medical comorbidities near the end of life.

7. Polypharmacy patterns in the last year of life in patients with dementia.

Review 8. Palliative care in chronic obstructive pulmonary disease: a review for clinicians.

9. Pharmacological management of co-morbid conditions at the end of life: is less more?

Review 10. Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.